Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKC53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,520
Award facts
- Contract value 100% obligated
- $13,519.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Cosentyx (secukinumab) 300 mg pre-filled pens in 2 ml presentations, valued at $13,519.97. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. As a child contract, this delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999 million and runs through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and branded and generic drugs across multiple therapeutic domains. The firm's competitive success in securing awards from the DLA, coupled with its substantial IDC vehicle, positions it as a critical vendor for ensuring pharmaceutical supply chain continuity for military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKC53?
SPE2DB25FKC53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FKC53 worth?
The government has obligated $13,520 on SPE2DB25FKC53.
Is contract SPE2DB25FKC53 an order under another contract?
Yes. SPE2DB25FKC53 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKC53 competed?
The extent of competition for SPE2DB25FKC53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award